` PMN (ProMIS Neurosciences Inc) vs S&P TSX Composite Index (Canada) Comparison - Alpha Spread

PMN
vs
S
S&P TSX Composite Index (Canada)

Over the past 12 months, PMN has underperformed S&P TSX Composite Index (Canada), delivering a return of 0% compared to the S&P TSX Composite Index (Canada)'s +21% growth.

Stocks Performance
PMN vs S&P TSX Composite Index (Canada)

Loading
PMN
S&P TSX Composite Index (Canada)
Add Stock
www.alphaspread.com

Performance Gap
PMN vs S&P TSX Composite Index (Canada)

Loading
PMN
S&P TSX Composite Index (Canada)
Difference
www.alphaspread.com

Performance By Year
PMN vs S&P TSX Composite Index (Canada)

Loading
PMN
S&P TSX Composite Index (Canada)
Add Stock

Competitors Performance
ProMIS Neurosciences Inc vs Peers

S&P TSX Composite Index (Canada)
PMN
ABBV
AMGN
GILD
VRTX
Add Stock

ProMIS Neurosciences Inc
Glance View

Market Cap
51.5m CAD
Industry
Biotechnology

ProMIS Neurosciences Inc is a CA-based company operating in Biotechnology industry. The company is headquartered in Toronto, Ontario and currently employs 5 full-time employees. The company went IPO on 2005-09-30. ProMIS Neurosciences, Inc. is a Canada-based development-stage biotechnology company. The firm is focused on the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases, including Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD). The firm is focused on the discovery engine, which is based on the use of two complementary algorithms: ProMIS and Collective Coordinates, which are used to predict targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. The firm is focused on developing antibody therapeutics for AD, ALS and PD. The firm has a wholly owned subsidiary is ProMIS Neurosciences (US) Inc. (ProMIS USA).

PMN Intrinsic Value
Not Available
Back to Top